• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

毒扁豆碱治疗躁狂症。

Physostigmine in mania.

作者信息

Davis K L, Berger P A, Hollister L E, Defraites E

出版信息

Arch Gen Psychiatry. 1978 Jan;35(1):119-22. doi: 10.1001/archpsyc.1978.01770250121012.

DOI:10.1001/archpsyc.1978.01770250121012
PMID:339869
Abstract

Seven men and one woman with primary affective disorder, mania, were given a slow intravenous infusion of physostigmine salicylate. In six patients, mood and thought content changed from mania toward depression as evaluated by either a visual analog mood scale or the Pettersen scale. Two other patients, who were the only predominantly irritable manics in the study, demonstrated little change in their hostility, although one became somewhat depressed. These findings are consistent with earlier reports of suppression of manic symptoms after physostigmine infusion in some but not all patients with mania. The pharmacologic mechanism of physostigmine reversal of manic symptoms may be the direct result of increased cholinergic activity or a result of the effect of increased cholinergic activity on other brain neurotransmitters.

摘要

七名患有原发性情感障碍(躁狂症)的男性和一名女性接受了水杨酸毒扁豆碱的缓慢静脉输注。通过视觉模拟情绪量表或彼得森量表评估,六名患者的情绪和思维内容从躁狂转向抑郁。另外两名患者是该研究中仅有的以易激惹为主的躁狂症患者,他们的敌意几乎没有变化,尽管其中一人变得有些抑郁。这些发现与早期关于在部分但并非所有躁狂症患者中输注毒扁豆碱后躁狂症状受到抑制的报道一致。毒扁豆碱逆转躁狂症状的药理机制可能是胆碱能活性增加的直接结果,或者是胆碱能活性增加对其他脑内神经递质产生作用的结果。

相似文献

1
Physostigmine in mania.毒扁豆碱治疗躁狂症。
Arch Gen Psychiatry. 1978 Jan;35(1):119-22. doi: 10.1001/archpsyc.1978.01770250121012.
2
Rebound phenomena in manic patients following physostigmine. Preliminary observations.毒扁豆碱治疗后躁狂患者的反弹现象。初步观察。
Neuropsychobiology. 1975;1(3):180-7. doi: 10.1159/000117490.
3
Cholinergic reversal of manic symptoms.
Lancet. 1972 Jun 3;1(7762):1236-7. doi: 10.1016/s0140-6736(72)90956-7.
4
Parasympathetic suppression of manic symptoms by physostigmine.毒扁豆碱对躁狂症状的副交感神经抑制作用。
Arch Gen Psychiatry. 1973 Apr;28(4):542-7. doi: 10.1001/archpsyc.1973.01750340072012.
5
Pharmacological investigations of the cholinergic imbalance hypotheses of movement disorders and psychosis.运动障碍和精神病胆碱能失衡假说的药理学研究。
Biol Psychiatry. 1978 Feb;13(1):23-49.
6
Cholinergic reversal of manic symptoms.
Lancet. 1973 Feb 24;1(7800):427-8. doi: 10.1016/s0140-6736(73)90285-7.
7
Physostigmine and lithium response in the schizophrenias.精神分裂症中毒扁豆碱和锂的反应
Am J Psychiatry. 1981 Aug;138(8):1078-81. doi: 10.1176/ajp.138.8.1078.
8
Clinical studies of the cholinergic deficit in Alzheimer's disease. II. Psychopharmacologic studies.阿尔茨海默病胆碱能缺陷的临床研究。II. 精神药理学研究。
J Am Geriatr Soc. 1985 Nov;33(11):749-57. doi: 10.1111/j.1532-5415.1985.tb04185.x.
9
Placebo-controlled study of quetiapine monotherapy in ambulatory bipolar spectrum disorder with moderate-to-severe hypomania or mild mania.安慰剂对照研究喹硫平单药治疗伴有中重度轻躁狂或轻度躁狂的门诊双相情感障碍。
J Affect Disord. 2010 Jul;124(1-2):157-63. doi: 10.1016/j.jad.2009.11.014. Epub 2009 Dec 5.
10
Physostigmine temporarily and dramatically reversing acute mania.毒扁豆碱可暂时且显著地逆转急性躁狂。
Gen Hosp Psychiatry. 1996 May;18(3):203-4. doi: 10.1016/0163-8343(96)00004-7.

引用本文的文献

1
Is SARS-CoV-2 a Risk Factor of Bipolar Disorder?-A Narrative Review.严重急性呼吸综合征冠状病毒2是双相情感障碍的危险因素吗?——一项叙述性综述。
J Clin Med. 2022 Oct 14;11(20):6060. doi: 10.3390/jcm11206060.
2
Efficacy and safety of scopolamine compared to placebo in individuals with bipolar disorder who are experiencing a depressive episode (SCOPE-BD): study protocol for a randomised double-blind placebo-controlled trial.与安慰剂相比,东莨菪碱对双相情感障碍抑郁发作患者的疗效和安全性(SCOPE-BD):一项随机双盲安慰剂对照试验的研究方案
Trials. 2022 Apr 23;23(1):339. doi: 10.1186/s13063-022-06270-4.
3
Drug Design Targeting the Muscarinic Receptors and the Implications in Central Nervous System Disorders.
靶向毒蕈碱受体的药物设计及其对中枢神经系统疾病的影响
Biomedicines. 2022 Feb 7;10(2):398. doi: 10.3390/biomedicines10020398.
4
Normalization of impaired emotion inhibition in bipolar disorder mediated by cholinergic neurotransmission in the cingulate cortex.正常化情绪抑制障碍:通过扣带皮层胆碱能神经传递介导的双相情感障碍。
Neuropsychopharmacology. 2022 Aug;47(9):1643-1651. doi: 10.1038/s41386-022-01268-7. Epub 2022 Jan 19.
5
New Pharmacological Interventions in Bipolar Disorder.双相情感障碍的新药理学干预措施
Curr Top Behav Neurosci. 2021;48:303-324. doi: 10.1007/7854_2020_181.
6
Cholinergic regulation of mood: from basic and clinical studies to emerging therapeutics.胆碱能调节情绪:从基础和临床研究到新兴治疗方法。
Mol Psychiatry. 2019 May;24(5):694-709. doi: 10.1038/s41380-018-0219-x. Epub 2018 Aug 17.
7
The Role of Muscarinic Receptors in the Pathophysiology of Mood Disorders: A Potential Novel Treatment?毒蕈碱受体在情绪障碍病理生理学中的作用:一种潜在的新型治疗方法?
Curr Neuropharmacol. 2015;13(6):739-49. doi: 10.2174/1570159x13666150612230045.
8
Future Directions for Pharmacotherapies for Treatment-resistant Bipolar Disorder.难治性双相情感障碍药物治疗的未来方向
Curr Neuropharmacol. 2015;13(5):656-62. doi: 10.2174/1570159x13666150630175841.
9
The catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited.双相情感障碍的儿茶酚胺能-胆碱能平衡假说再探讨。
Eur J Pharmacol. 2015 Apr 15;753:114-26. doi: 10.1016/j.ejphar.2014.05.063. Epub 2014 Aug 5.
10
The prominent role of stimulus processing: cholinergic function and dysfunction in cognition.刺激处理的突出作用:胆碱能功能与认知障碍。
Curr Opin Neurol. 2011 Aug;24(4):364-70. doi: 10.1097/WCO.0b013e328348bda5.